Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optical Coherence Tomography-Guided PCI with Single-Antiplatelet Therapy
2020-003437-38Phase 2Active
- Sponsor
- AMC Medical Research
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of prasugrel and ticagrelor in non–ST-segment elevation acute coronary syndrome (NSTE-ACS) (2 arms), sponsored by AMC Medical Research. Primary endpoint: Primary ischemic endpoint at 6 months. Started Dec 2020; status: active.
02
Drugs
prasugrelticagrelor
03
Conditions
non–ST-segment elevation acute coronary syndrome (NSTE-ACS)
Beyond the preview
Go deeper on 2020-003437-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003437-38.